Skip to content

Clinical trials

Phase 1/2 Myelodysplastic Syndromes trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 1/2 Country / region: Netherlands Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20131
20141
20161
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Terminated2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Constellation Pharmaceuticals1
Ellipses Pharma1
European Organisation for Research and Treatment of Cancer - EORTC1
Gamida Cell ltd1
Incyte Corporation1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes6
Leukemia, Myeloid, Acute5
Hematologic Neoplasms2
Leukemia2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Primary Myelofibrosis2
Bone Marrow Diseases1
Congenital Abnormalities1
Hematologic Diseases1
Leukemia, Erythroblastic, Acute1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.